logo
15:58 Mar 27

Emcure Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1652.70
+59.30 (+3.72%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Emcure Pharmaceuticals Ltd. Financials

Emcure Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1652.70
+59.30 (+3.72%)
15:58 Mar 27
Quality
image/svg+xml

82/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

65/100
Technically Moderately Bullish

Strength

10

Weakness

4

Opportunity

1

Threats

0

15.32 %

ROE %

8.27 %

ROA %

45.88

EPS

234.65

BVPS

8.62 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
5855.39 5985.81 6658.25 7896
Operating Expenses +
4525.47 4804.63 5428.52 6421.62
Raw Material
2378.55 2193.83 2665.61 3410.14
Increase Decrease in Cost
-145.4 66.69 -190.19 -263.53
Other Manufacturing Expense
0 0 0 0
Employee Cost
1011.82 1117.33 1292.08 1446.29
Miscellaneous Expenses
3445.4 3521.26 4325.98 5595.2
Operating Profit
1329.92 1181.18 1229.73 1474.38
Other Income
63.47 45.9 56.99 67.26
Depreciation
244.86 260.12 312.41 384.13
Interest
175.98 213.61 237.15 175.78
Profit before tax and exceptio..
972.55 753.36 737.16 981.73
Exceptional Items
0 -6.15 -9.93 -10.38
PBT
972.55 747.22 727.23 971.35
Provision for Taxation
269.99 185.37 199.65 263.88
Net Profit
702.56 561.84 527.58 707.47
NET Profit after MI
662.2 532.02 498.18 681.33
EPS
36.62 29.42 27.54 36.43
Operating Profit Margin (%)
22.71 19.73 18.47 18.67
Net Profit Margin (%)
11.31 8.89 7.48 8.63

Emcure Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: